Literature DB >> 12773553

The RNA binding domain of Jerky consists of tandemly arranged helix-turn-helix/homeodomain-like motifs and binds specific sets of mRNAs.

Wencheng Liu1, Jeremy Seto, Etienne Sibille, Miklos Toth.   

Abstract

A deficit in the Jerky protein in mice causes recurrent seizures reminiscent of temporal lobe epilepsy. Jerky is present in mRNA particles in neurons. We show that the N-terminal 168 amino acids of Jerky are necessary and sufficient for mRNA binding. The binding domain is similar to the two tandemly arranged homeodomain-like helix-turn-helix DNA binding motifs of centromere binding protein B. The putative helix-turn-helix motifs of Jerky can also bind double-stranded DNA and represent a novel mammalian RNA/DNA binding domain. Microarray analysis identified mRNAs encoding proteins involved in ribosome assembly and cellular stress response that specifically bound to the RNA binding domain of Jerky both in vitro and in vivo. These data suggest that epileptogenesis in Jerky-deficient mice most likely involves pathways associated with ribosome biogenesis and neuronal survival and/or apoptosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12773553      PMCID: PMC156124          DOI: 10.1128/MCB.23.12.4083-4093.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  54 in total

1.  Dominant partial epilepsies. A clinical, electrophysiological and genetic study of 19 European families.

Authors:  F Picard; S Baulac; P Kahane; E Hirsch; R Sebastianelli; P Thomas; F Vigevano; P Genton; R Guerrini; C A Gericke; I An; G Rudolf; A Herman; A Brice; C Marescaux; E LeGuern
Journal:  Brain       Date:  2000-06       Impact factor: 13.501

Review 2.  Heat shock proteins: regulators of stress response and apoptosis.

Authors:  A Samali; S Orrenius
Journal:  Cell Stress Chaperones       Date:  1998-12       Impact factor: 3.667

3.  Familial temporal lobe epilepsy: a clinically heterogeneous syndrome.

Authors:  F Cendes; I Lopes-Cendes; E Andermann; F Andermann
Journal:  Neurology       Date:  1998-02       Impact factor: 9.910

4.  Release of mitochondrial cytochrome c and DNA fragmentation after cold injury-induced brain trauma in mice: possible role in neuronal apoptosis.

Authors:  Y Morita-Fujimura; M Fujimura; M Kawase; S F Chen; P H Chan
Journal:  Neurosci Lett       Date:  1999-06-04       Impact factor: 3.046

5.  Autosomal dominant nocturnal frontal lobe epilepsy in a Spanish family with a Ser252Phe mutation in the CHRNA4 gene.

Authors:  A Sáenz; J Galán; C Caloustian; F Lorenzo; C Márquez; N Rodríguez; M D Jiménez; J J Poza; A M Cobo; D Grid; J F Prud'homme; A López de Munain
Journal:  Arch Neurol       Date:  1999-08

6.  Epilepsy and EEG findings in males with fragile X syndrome.

Authors:  S A Musumeci; R J Hagerman; R Ferri; P Bosco; B Dalla Bernardina; C A Tassinari; G B De Sarro; M Elia
Journal:  Epilepsia       Date:  1999-08       Impact factor: 5.864

7.  Homeodomain position 54 specifies transcriptional versus translational control by Bicoid.

Authors:  D Niessing; W Driever; F Sprenger; H Taubert; H Jäckle; R Rivera-Pomar
Journal:  Mol Cell       Date:  2000-02       Impact factor: 17.970

8.  Autosomal dominant lateral temporal epilepsy: clinical and genetic study of a large Basque pedigree linked to chromosome 10q.

Authors:  J J Poza; A Sáenz; A Martínez-Gil; N Cheron; A M Cobo; M Urtasun; J F Martí-Massó; D Grid; J S Beckmann; J F Prud'homme; A López de Munain
Journal:  Ann Neurol       Date:  1999-02       Impact factor: 10.422

9.  Targeting gene expression to the head: the Drosophila orthodenticle gene is a direct target of the Bicoid morphogen.

Authors:  Q Gao; R Finkelstein
Journal:  Development       Date:  1998-11       Impact factor: 6.868

10.  Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner.

Authors:  E A Slee; M T Harte; R M Kluck; B B Wolf; C A Casiano; D D Newmeyer; H G Wang; J C Reed; D W Nicholson; E S Alnemri; D R Green; S J Martin
Journal:  J Cell Biol       Date:  1999-01-25       Impact factor: 10.539

View more
  8 in total

Review 1.  DNA transposons and the evolution of eukaryotic genomes.

Authors:  Cédric Feschotte; Ellen J Pritham
Journal:  Annu Rev Genet       Date:  2007       Impact factor: 16.830

2.  Putative CENP-B paralogues are not present at mammalian centromeres.

Authors:  Owen J Marshall; K H Andy Choo
Journal:  Chromosoma       Date:  2011-11-13       Impact factor: 4.316

3.  Jerky/Earthbound facilitates cell-specific Wnt/Wingless signalling by modulating β-catenin-TCF activity.

Authors:  Hassina Benchabane; Nan Xin; Ai Tian; Brian P Hafler; Kerrie Nguyen; Ayah Ahmed; Yashi Ahmed
Journal:  EMBO J       Date:  2011-03-11       Impact factor: 11.598

4.  Convergent domestication of pogo-like transposases into centromere-binding proteins in fission yeast and mammals.

Authors:  Claudio Casola; Donald Hucks; Cédric Feschotte
Journal:  Mol Biol Evol       Date:  2007-10-16       Impact factor: 16.240

5.  Chromosomal minimal critical regions in therapy-related leukemia appear different from those of de novo leukemia by high-resolution aCGH.

Authors:  Nathalie Itzhar; Philippe Dessen; Saloua Toujani; Nathalie Auger; Claude Preudhomme; Catherine Richon; Vladimir Lazar; Véronique Saada; Anelyse Bennaceur; Jean Henri Bourhis; Stéphane de Botton; Alain Bernheim
Journal:  PLoS One       Date:  2011-02-14       Impact factor: 3.240

6.  Crystal structure of an anti-CRISPR protein, AcrIIA1.

Authors:  Donghyun Ka; So Young An; Jeong-Yong Suh; Euiyoung Bae
Journal:  Nucleic Acids Res       Date:  2018-01-09       Impact factor: 16.971

Review 7.  Post-transcriptional gene regulation: from genome-wide studies to principles.

Authors:  R E Halbeisen; A Galgano; T Scherrer; A P Gerber
Journal:  Cell Mol Life Sci       Date:  2008-03       Impact factor: 9.261

8.  Mining expressed sequence tags identifies cancer markers of clinical interest.

Authors:  Fabien Campagne; Lucy Skrabanek
Journal:  BMC Bioinformatics       Date:  2006-11-01       Impact factor: 3.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.